Skip to main content
TIANYU BIO-TECHNOLOGY CO.,LTD. logo

TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings

Ticker · 603717 ISIN · CNE1000030W1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,621 across all filing types
Latest filing 2024-08-13 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603717

About TIANYU BIO-TECHNOLOGY CO.,LTD.

https://www.tianyubiotech.com/

TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.

Recent filings

Filing Released Lang Actions
中德证券有限责任公司关于天域生物科技股份有限公司使用部分闲置募集资金暂时补充流动资金的核查意见
Regulatory Filings Classification · 95% confidence The document is a verification opinion from a sponsoring securities company regarding the use of idle raised funds by Tianyu Biotechnology Co., Ltd. It details the approval and use of funds raised through a non-public stock issuance, including amounts, usage plans, and compliance with regulatory requirements. The document is not a full financial report but rather a regulatory compliance and verification statement related to the use of raised funds. It does not contain financial statements or comprehensive financial data but focuses on the management and use of capital raised. This fits the category of a Regulatory Filing (RNS), as it is a compliance-related announcement and verification rather than a full report or financial statement.
2024-08-13 Chinese
关于拟变更公司证券简称的公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement from the company's board regarding the proposed change of the company's securities abbreviation from '天域生态' to '天域生物'. It includes details about the board meeting approving the change, the reason for the change related to company strategy and business structure, and the regulatory process involving the Shanghai Stock Exchange. The document is short (1030 characters) and does not contain financial data, financial statements, or detailed reports. It is an announcement about a corporate action related to securities identification, not a financial report or regulatory filing of financial results. Therefore, it fits best into the category of Regulatory Filings (RNS), which is a fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-08-08 Chinese
关于公司完成工商变更登记并取得营业执照的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Tianyu Biotechnology Co., Ltd. regarding the completion of business registration changes and obtaining a new business license. It details changes approved in board and shareholder meetings, including company name change, business scope adjustment, and amendments to the company charter. The document is short (1037 characters) and serves as a formal notification of these corporate changes rather than a detailed report or financial statement. There is no financial data, audit information, or regulatory certification content. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about corporate administrative changes that do not fit other specific categories.
2024-08-05 Chinese
关于控股股东协议转让公司部分股份完成过户登记的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the completion of a share transfer agreement between the controlling shareholders and a private equity fund. It details the number of shares transferred, the percentage of total shares, the transfer price, and the updated shareholding structure. It explicitly states that the transfer does not affect control or governance and complies with relevant laws and regulations. There is no financial data, no report attached or referenced as being published, and no mention of a meeting or voting results. This is a typical announcement of a change in major shareholding or equity interest. Therefore, the document fits the category of Major Shareholding Notification (MRQ). The document length is short (1602 characters), consistent with an announcement rather than a full report.
2024-07-31 Chinese
德恒上海律师事务所关于天域生态环境股份有限公司2024年第三次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the procedural legality and validity of a company's 2024 third extraordinary general meeting of shareholders. It details the convening, attendance, voting procedures, and results of the shareholders meeting. The document does not contain financial statements or financial performance data, nor is it an announcement of a report publication. It is focused on the legal validation of the shareholder meeting and its resolutions. This type of document is best classified as a Declaration of Voting Results & Voting Rights Announcements (DVA), as it confirms the voting results and legality of the shareholder meeting proceedings.
2024-07-24 Chinese
公司章程（2024年07月24日修订）
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of Tianyu Bio-Technology Co., Ltd., dated July 24, 2024. It contains detailed chapters on company organization, shareholder rights, board of directors, management, financial accounting, profit distribution, auditing, meetings, and amendments to the articles. It is a comprehensive governance document outlining the internal rules, structure, and governance practices of the company. There is no indication that this is an annual report, earnings release, or any other financial report. It is not a short announcement or certification but a full governance charter. Therefore, the document best fits the category of Governance Information (CGR).
2024-07-24 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.